News

Trulicity comes in a single-dose pen and does not require the patient to mix, measure, or handle the needle and it is not recommended as first-line therapy for

With the exclusive license, Pharco will now be able to expand its licensed territory to one or more additional countries in the Middle East and North Africa (MENA)

Evolocumab inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that reduces the liver’s ability to remove low-density lipoprotein cholesterol (LDL-C) or bad cholesterol from the blood. The

DCV is a fixed-dose combination of daclatasvir 30mg with asunaprevir 200mg (ASV) and beclabuvir 75mg (BCV). Primary endpoint for the two trials was the percentage of patients who

Alios, which is focused on developing therapies for viral diseases, will now be part of the infectious diseases therapeutic area of the Janssen Pharmaceutical Companies of J&J. The

DLBCL accounts for about 25% of all NHLs in the developed world and it occurs primarily in older individuals, while the disease can also occur in children and

The pancreatic cancer treatment includes implanting living cells that have been encapsulated in pin-head sized, cellulose-based, protective cocoons through the use of the Cell-in-a-Box technology, followed by the

Conducted in 35 centres in Korea, Taiwan, Hong Kong and India, the trial is designed to assess the safety and efficacy of intravenous Brinavess in patients with recent-onset

AVP-825 is a drug-device combination product consisting of low-dose sumatriptan powder, delivered intranasally utilizing a novel Breath Powered delivery technology. The FDA has raised questions regarding the human